Indicators that a patient may require more frequent BoNT-A injections include a decrease in treatment effect duration, worsening of symptoms before the next scheduled injection, or a decline in functional abilities. Patients should be reassessed regularly, typically every 12 weeks, to determine the need for adjustments in the treatment plan.